Gastric secretion and proton pump inhibitors;Secreción gástrica e inhibidores de bomba de protons

Revista Colombiana de Gastroenterologia

Volumn 25, Issue 1, 2010, Pages 94-98

  Cienfuegos, Alfredo ^a  

^a CENTRO MÉDICO IMBANACO   (Colombia)

Author keywords

Gastric secretion; Physiology; Protons pump inhibitors

Indexed keywords

EID: 77956965596     PISSN: 01209957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schubert ML. Gastric secretion. Current Opin Gastroent 2005; 21: 633-757.
2. Wolfe MM, Soll AH. The physiology of gastric acid secretion. N Engl J Med 1998; 319: 1707.
3. Feldman M. Gastric secretion En Feldman: Sleisenger and Fordtrans. Gastrointestinal and liver disease. WB Saunders company Philadelphia; 2006.
4. Del Valle J, Todisco A. Gastric secretion. En Yamada T, Alpers DH, Kaplowitz N, Laines L, Owyang C, Powell DW, Eds. Textbook of Gastroenterology 4th Edition. Philadelphia: Lippincott William and Williams 2003. p. 266-307.
5. AS Giraud, C Jackson, TR Memheniott LM Judd. Differentiation of the gastric mucosa IV: Role of trefoil peptides and I.L.-6 cytokine family signaling in gastric homeostasis. Am J Physiol Gastrointest liver Physiol 2007; 292: G1-G5.
6. Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal refl ux disease and stress erosive syndrome Gastroenterology 2000; 118: S9.
7. Hattlebakk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and breakthrough on different regimen of omeprazole 40 mg daily. Aliment Pharmacol Ther 1998; 12: 1235-1240.
8. Peghini PL, Katz PO, Castell DO. Ranitidine control nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115: 1335-39.
9. Katz PO, Anderson R Khoury, Castell DO. Gastro oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitor. Aliment Pharmacol Ther 1998; 12: 1231-1234.
10. Hammer J, Schmidt B. Effect of splitting dose of omeprazole on gastric acidity and nocturnal acid Breakthrough. Aliment Pharmacol Ther 2005; 22: 129-134.
11. Katz PO. Review article: Putting immediate release proton -pump inhibitors into clinical practice- improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. Aliment Pharmacol Thera 2005; 22(Suppl 3) 32-38.
12. Rackoff A, Agrawal A, Hila I, et al. Histamine 2 receptor antagonist at night improve G.E.R.D. symptoms for patients on PPI therapy. Dis Esophagus 2005; 18: 370.
13. Fackler WK, Our TM, Vaezy MF, et al. Long term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 2002; 122: 625-632.
14. Fass R. Proton pump Inhibitor failure-What are the therapeutics options? Am J Gastroenterol 2009; 104: S33-S38.
15. Katz PO, Scheiman J M, Barkun AN. Review article: Acid related disease-What are the unmet clinical needs? Aliment Pharmacol Ther 2006; 23(supp.2): 9-22.
16. Mc Quaidi KR, Laine L. Early heartburn relief with PPI: A systematic review and meta-analysis of clinical trial. Clin Gastroenterol Hepato 2005; 3: 553.
17. Carmack S, Genta R, Schul C, Saboorian H. The current spectrum of gastric polyps: A one year national study of over 120.000 patients. Am J Gastroenterol 2009; 104: 1524-532.
18. Wang J, Varro A, Lightdale C, et al. Elevated serum gastrin is associated with a history of advanced neoplasia in Barrets esophagus Am J Gastroenterol Advance on line publication 10 nov 2009; doi: 10.1038/ajg 2009.629
19. Isogna K. The effect of proton pump Inhibitors on mineral metabolism. Am J Gastroenterol 2009; 104: S2-S4.
20. Dial Sandra. Proton pump Inhibitor use and enteric infection. Am J Gastroenterol 2009; 104: S10-S16.
21. Vakil N Acid inhibition and infections outside the gastrointestinal Tract. Am J Gastroenterol 2009; 104: S17-S20.
22. Laine L. Proton pump inhibitor and bone fctures 2009; 104: S21-S26.